Literature DB >> 6648363

High-dose intravenous immunoglobulin for post-transfusion purpura.

T K Glud, S Rosthøj, M K Jensen, B Laursen, N Grunnet, C Jersild.   

Abstract

Successful treatment of a case of post-transfusion purpura with high-dose i.v. human immunoglobulin is reported. A 62-year-old multiparous woman developed severe thrombocytopenia in the wake of transfusions given during and after vascular surgery. A platelet alloantibody with anti-Zwa-specificity was demonstrable by an indirect immunofluorescence technique. A single infusion of Sandoglobulin 1 g/kg body weight caused an immediate platelet response with cessation of haemorrhagic manifestations within 12 h, and the platelet count became normal within 3 d. Thrombocytopenia recurred 8 d after the infusion, but one further dose of Sandoglobulin 0.5 g/kg body weight caused definitive reversal of the thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6648363     DOI: 10.1111/j.1600-0609.1983.tb01551.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  4 in total

1.  The efficacy of PlA1-negative platelet transfusion therapy in posttransfusion purpura.

Authors:  S M Lippman; G E Lizak; S K Foung; F C Grumet
Journal:  West J Med       Date:  1988-01

2.  Post-transfusion purpura following open heart surgery: management by high dose intravenous immunoglobulin infusion.

Authors:  W S Walker; P L Yap; D C Kilpatrick; F E Boulton; R J Crawford; C T Sang
Journal:  Blut       Date:  1988-11

Review 3.  Red blood cell transfusion risks in patients with end-stage renal disease.

Authors:  Yvette C Tanhehco; Jeffrey S Berns
Journal:  Semin Dial       Date:  2012-06-11       Impact factor: 3.455

Review 4.  High-dose IgG for post-transfusion purpura-revisited.

Authors:  C Mueller-Eckhardt; V Kiefel
Journal:  Blut       Date:  1988-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.